Abstract
A Dibenamine analogue was administered orally to five hypertensive and 10 normotensive subjects over periods from 14 to 21 days. Its adrenergic blocking effect was studied by observing blood pressure, pulse rate, skin temperature of the toes and the pupillary mechanism. Nasal congestion, weakness, listlessness, dizziness, drowsiness and palpitation were persistent sequelae of adrenergic blocking. The drug was found valuable for investigation of autonomous nervous system functions and may hold promise as a therapeutic agent for the treatment of arterial insufficiency and some types of hypertensive subjects.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
